Seeking Alpha

XNCR
  Xencor, Inc. - NASDAQ

11/27/2014, 6:23 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
XNCR vs. ETF Alternatives
Company Description
Xencor Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.